Diamanti-Kandarakis, Evanthia <br/><br/>
The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels.  [electronic resource] 

 -  European journal of endocrinology  Jun 2004 
 - 793-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0804-4643 
<br/><br/><label>Standard No.: </label>10.1530/eje.0.1500793  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Alleles<br/>Blood Glucose--analysis<br/>Body Constitution<br/>Body Mass Index<br/>Case-Control Studies<br/>Female<br/>Gene Frequency<br/>Genotype<br/>Humans<br/>Insulin--blood<br/>Plasminogen Activator Inhibitor 1--blood<br/>Polycystic Ovary Syndrome--blood<br/>Polymorphism, Genetic<br/>Promoter Regions, Genetic--genetics<br/>Testosterone--blood